Track GSK and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
GSK - GlaxoSmithKline PLC ADR (GSK) has a earnings per share of $1.26, up 5.0% over the past year.
Latest EPS (Actual)
$1.26
Beat Rate
100.0%
Most Recent
Beat
| Date | Estimated EPS | Actual EPS | Result | Surprise % |
|---|---|---|---|---|
| Apr 2026 | $1.16 | $1.26 | Beat | +8.62% |
| Feb 2026 | $0.62 | $0.70 | Beat | +12.90% |
| Oct 2025 | $1.26 | $1.46 | Beat | +15.87% |
| Jul 2025 | $1.11 | $1.24 | Beat | +11.71% |
| Apr 2025 | $1.04 | $1.20 | Beat | +15.38% |
| Feb 2025 | $0.49 | $0.58 | Beat | +18.37% |
| Oct 2024 | $1.16 | $1.29 | Beat | +11.21% |
| Jul 2024 | $0.98 | $1.11 | Beat | +13.27% |
Earnings per share (EPS) is a company's net profit divided by its number of outstanding shares. It shows how much profit is attributable to each share and is one of the most closely watched gauges of profitability.